Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero

Environmental Health Perspectives

Volumn 121, Issue 8, 2013, Pages 971-977

  Koestler, Devin C ^a   Avissar Whiting, Michele ^b   Andres Houseman, E ^c   Karagas, Margaret R ^a   Marsit, Carmen J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Arsenic; Cord blood; DNA methylation; Epigenetics; Illumina 450K; In utero arsenic exposure

Indexed keywords

ARSENIC; CREATININE; ESTROGEN RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TAP WATER;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CPG ISLAND; CREATININE URINE LEVEL; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PYROSEQUENCING; UMBILICAL CORD BLOOD; URINE LEVEL;

ADULT; ARSENIC; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; CPG ISLANDS; DNA METHYLATION; FEMALE; FETAL BLOOD; HUMANS; MASS SPECTROMETRY; MATERNAL EXPOSURE; NEW HAMPSHIRE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; WATER POLLUTANTS, CHEMICAL; YOUNG ADULT;

EID: 84881010102     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205925     Document Type: Article

References (58)

1. Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y, Hoque AM, et al. 2012. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci 129(2):305-314; doi:10.1093/toxsci/kfs202.
2. Banerjee N, Banerjee S, Sen R, Bandyopadhyay A, Sarma N, Majumder P, et al. 2009. Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J Clin Immunol 29:582-594.
3. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192-200.
4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc B Met 57(1):289-300.
5. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD. 2009. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. J Expo Sci Environ Epidemiol 19:59-68.
6. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, et al. 2006. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 89:431-437.
7. Chen H, Liu J, Merrick BA, Waalkes MP. 2001. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol Carcinog 30:79-87.
8. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, et al. 2011. Arsenic exposure from drinking water and mortality from cardiovascular disease in bangladesh: prospective cohort study. BMJ 342:d2431; doi:10.1136/bmj.d2431 [Online 5 May 2011].
9. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. 1998. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44:185-190.
10. Davis CD, Uthus EO, Finley JW. 2000. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr 130:2903-2909.
11. Du J, Zhou N, Liu H, Jiang F, Wang Y, Hu C, et al. 2012. Arsenic induces functional re-expression of estrogen receptor alpha by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS One 7:e35957; doi:10.1371/journal.pone.0035957 [Online 27 April 2012].
12. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. 2010. Comparison of beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 11:587; doi:10.1186/1471-2105-11-587 [Online 30 November 2010].
13. Ferreira HJ, Heyn H, Moutinho C, Esteller M. 2012. CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer. RNA Biol 9:881-890; doi:10.4161/rna.19353 [Online 23 May 2012].
14. Gamble MV, Liu X. 2005. Urinary creatinine and arsenic metabolism [Letter]. Environ Health Perspect 113:A442.
15. Gilbert-Diamond D, Cottingham KL, Gruber JF, Punshon T, Sayarath V, Gandolfi AJ, et al. 2011. Rice consumption contributes to arsenic exposure in US women. Proc Natl Acad Sci USA 108:20656-20660.
16. Gong G, O'Bryant SE. 2012. Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural texas counties. Environ Res 113:52-57.
17. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, et al. 2007. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect 115:1503-1509.
18. Harper KN, Peters BA, Gamble MV. 2013. Batch effects and pathway analysis: two potential perils in cancer studies involving DNA methylation array analysis. Cancer Epidemiol Biomarkers Prev 22(6):1052-1060; doi:10.1158/1055-9965.
19. Hopenhayn-Rich C, Biggs ML, Smith AH. 1998. Lung and kidney cancer mortality associated with arsenic in drinking water in cordoba, argentina. Int J Epidemiol 27:561-569.
20. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. 2012. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13:86; doi:10.1186/1471-2105-13-86 [Online 8 May 2012].
21. Intarasunanont P, Navasumrit P, Woraprasit S, Chaisatra K, Suk WA, Mahidol C, et al. 2012. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Health 11:31; doi:10.1186/1476-069X-11-31 [Online 2 May 2012].
22. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. 2009. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41:178-186.
23. Johnson WE, Li C, Rabinovic A. 2007. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8:118-127.
24. Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, Rahman M, et al. 2012. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect 120:1061-1066.
25. Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, et al. 2009. Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 117:455-460.
26. Koestler DC, Christensen B, Karagas MR, Marsit CJ, Langevin SM, Kelsey KT, et al. 2013. Blood-based profiles of DNA methylation predict the underlying distribution of cell types: a validation analysis. Epigenetics. Available: http://www.landesbioscience.com/journals/epigenetics/article/25430/ [Online 25 June 2013].
27. Koestler DC, Marsit CJ, Christensen BC, Accomando WP, Langevin SM, Houseman EA, et al. 2012. Peripheral blood immune cell methylation profiles are associated with non-hematopoietic cancers. Cancer Epidemiol Biomarkers Prev 21(8):1293-1302; doi:10.1158/1055-9965.EPI-12-0361.
28. Kozul CD, Ely KH, Enelow RI, Hamilton JW. 2009a. Low-dose arsenic compromises the immune response to influenza A infection in vivo. Environ Health Perspect 117:1441-1447.
29. Kozul CD, Hampton TH, Davey JC, Gosse JA, Nomikos AP, Eisenhauer PL, et al. 2009b. Chronic exposure to arsenic in the drinking water alters the expression of immune response genes in mouse lung. Environ Health Perspect 117:1108-1115.
30. Kuan PF, Wang S, Zhou X, Chu H. 2010. A statistical framework for Illumina DNA methylation arrays. Bioinformatics 26:2849-2855.
31. Le XC, Ma M, Cullen WR, Aposhian HV, Lu X, Zheng B. 2000. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 108:1015-1018.
32. Lee CH, Wu SB, Hong CH, Liao WT, Wu CY, Chen GS, et al. 2011. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J Pathol 178:2066-2076.
33. Lorenzen JM, Martino F, Thum T. 2012. Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 107:245; doi:10.1007/s00395-012-0245-9.
34. Majumdar S, Chanda S, Ganguli B, Mazumder DN, Lahiri S, Dasgupta UB. 2010. Arsenic exposure induces genomic hypermethylation. Environ Toxicol 25:315-318.
35. Marchiset-Ferlay N, Savanovitch C, Sauvant-Rochat MP. 2012. What is the best biomarker to assess arsenic exposure via drinking water? Environ Int 39:150-171.
36. Marsit CJ, Christensen BC, Houseman EA, Karagas MR, Wrensch MR, Yeh RF, et al. 2009. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 30:416-422.
37. Martin-Chouly C, Morzadec C, Bonvalet M, Galibert MD, Fardel O, Vernhet L. 2011. Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Mol Immunol 48:956-965.
38. Mass MJ, Wang L. 1997. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 386:263-277.
39. Mattingly CJ, Hampton TH, Brothers KM, Griffin NE, Planchart A. 2009. Perturbation of defense pathways by low-dose arsenic exposure in zebrafish embryos. Environ Health Perspect 117:981-987.
40. Naujokas MF, Anderson B, Ahsan H, Aposhian HV, Graziano JH, Thompson C, et al. 2013. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect 121:295-302.
41. Pilsner JR, Hall MN, Liu X, Ilievski V, Slavkovich V, Levy D, et al. 2012. Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA. PLoS One 7:e37147; doi:10.1371/journal.pone.0037147 [Online 25 May 2012].
42. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, et al. 2007. Genomic methylation of peripheral blood leukocyte DNA: Influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr 86:1179-1186.
43. Rahman A, Persson LA, Nermell B, El Arifeen S, Ekstrom EC, Smith AH, et al. 2010. Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology 21:797-804.
44. Rahman A, Vahter M, Smith AH, Nermell B, Yunus M, El Arifeen S, et al. 2009. Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol 169:304-312.
45. Reichard JF, Puga A. 2010. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2:87-104.
46. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L. 2011. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect 119:11-19.
47. Rodak BF, Fritsma GA, Doig K. 2007. Hematology: Clinical Principles and Applications. 3rd ed. Philadelphia:W.B. Saunders.
48. Selgrade MK. 2007. Immunotoxicity: the risk is real. Toxicol Sci 100:328-332.
49. Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, et al. 2001. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-γ in vascular smooth muscle cells. Endocrinology 142:3125-3134.
50. Tseng CH. 2004. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol 197:67-83.
51. U.S. EPA (U.S. Environmental Protection Agency). 2001. National primary drinking water regulations; arsenic and clarifications to compliance and new source contaminants monitoring. Fed Reg 66(114):6976-7066.
52. Vahter M. 2008. Health effects of early life exposure to arsenic. Basic Clin Pharmacol Toxicol 102:204-211.
53. Walter U, Santamaria P. 2005. CD8+ T cells in autoimmunity. Curr Opin Immunol 17:624-631.
54. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, et al. 2010. Implications of LINE 1 methylation for bladder cancer risk in women. Clin Cancer Res 16:1682-1689.
55. Winnefeld M, Lyko F. 2012. The aging epigenome: DNA methylation from the cradle to the grave. Genome Biol 13:165; doi:10.1186/gb4033.
56. Yang HH, Hu N, Wang C, Ding T, Dunn BK, Goldstein AM, et al. 2010. Influence of genetic background and tissue types on global DNA methylation patterns. PLoS One 5:e9355; doi:10.1371/journal.pone.0009355.
57. Yunus M, Sohel N, Hore SK, Rahman M. 2011. Arsenic exposure and adverse health effects: a review of recent findings from arsenic and health studies in Matlab, Bangladesh. Kaohsiung J Med Sci 27:371-376.
58. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. 1997. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 94:10907-10912.